Digital Veterinary Summit 2021

Digital Veterinary Summit 2021

Advancing Digital Innovation To Deliver Actionable Insights In The Veterinary Clinic

Register Now
VIRTUAL SUMMIT | EDT Timezone
27-28 July, 2021

Apply for the Digital Technology Showcase where 6 of the most promising digital veterinary innovators in the ecosystem - with a focus on companion animals - are chosen by our Selection Committee to introduce their products in a quick-fire round of presentations.

Free Pre-Event Q&A Panel with VSGD

Why Attend

The animal health ecosystem is going through a digital transformation, as disruptive tools reshape the way we think about the prevention and prediction of disease, and veterinarians are increasingly using a variety of new digital solutions to empower them in the workplace and improve their productivity. The growing ‘millenialization’ of pet ownership has resulted in a demand for digital solutions that directly connect the pet owner with the clinic. With 30% of pet owners not currently visiting clinics, practitioners are being forced to adopt solutions that are designed to improve the pet-owner/vet relationship and tackle the longstanding issue of compliance.

At the Digital Veterinary Summit, we bring together 150+ executives from across the animal health and veterinary industry, to examine the sector’s digital trends and dynamics, and showcase the industry’s most exciting emerging technologies. 

This is a companion animal focused event showcasing technology innovation, platforms and services for pet owners and the latest digital solutions for veterinary practice.

DIGITAL INNOVATION SHOWCASE

6 digital veterinary technology innovators, handpicked by the prestigious selection committee, introduce themselves and their innovations and achievements on the main stage.

If you’re an emerging company with an exciting and disruptive technology, apply to pitch in the showcase today.

Applications are now CLOSED. We will be revealing our finalists shortly.

 

2021 Global Advisory Board

Author:

Sébastien Huron

Chairman of the Executive Board and CEO
Virbac Santé Animale

Sébastien Huron

Chairman of the Executive Board and CEO
Virbac Santé Animale

Author:

Jean-Luc Michel

Senior Vice President, Head of Global Strategic Marketing
Boehringer Ingelheim

After graduating from the University of Pharmacy of Lyon with a Doctorate and from EM Lyon Business School with an MBA, Jean-Luc Michel started his career by creating his own consultancy company. He joined the pharmaceutical industry in 1991 spending 10 years developing a solid expertise in consumer healthcare and nutrition. During this period, he held a variety of senior marketing and sales management positions in France at Monsanto (Searle) and at Johnson&Johnson / Merck & Co where he was an Executive Committee member of the French subsidiary.

In 2001, Jean-Luc joined Merial, a leader in the animal health industry, where he held some key senior roles, such as EMEA Marketing Director of the Companion Animal Global Enterprise; Head of Marketing EMEA; Executive Marketing Director (Pet Business) in the US; VP, Head of Pet Vet Business Unit; and in 2016 joined the Executive Committee of Merial as Head of Global Commercial Development.

After the acquisition of Merial by Boehringer Ingelheim, Jean-Luc was appointed Head of Global Companion Animal Strategic Business Unit and became a member of the Executive Committee of the Boehringer Ingelheim Animal Health Business Unit.

Jean-Luc Michel

Senior Vice President, Head of Global Strategic Marketing
Boehringer Ingelheim

After graduating from the University of Pharmacy of Lyon with a Doctorate and from EM Lyon Business School with an MBA, Jean-Luc Michel started his career by creating his own consultancy company. He joined the pharmaceutical industry in 1991 spending 10 years developing a solid expertise in consumer healthcare and nutrition. During this period, he held a variety of senior marketing and sales management positions in France at Monsanto (Searle) and at Johnson&Johnson / Merck & Co where he was an Executive Committee member of the French subsidiary.

In 2001, Jean-Luc joined Merial, a leader in the animal health industry, where he held some key senior roles, such as EMEA Marketing Director of the Companion Animal Global Enterprise; Head of Marketing EMEA; Executive Marketing Director (Pet Business) in the US; VP, Head of Pet Vet Business Unit; and in 2016 joined the Executive Committee of Merial as Head of Global Commercial Development.

After the acquisition of Merial by Boehringer Ingelheim, Jean-Luc was appointed Head of Global Companion Animal Strategic Business Unit and became a member of the Executive Committee of the Boehringer Ingelheim Animal Health Business Unit.

Author:

Marc Prikazsky

Chairman and Chief Executive Officer
CEVA Santé Animale S.A

Marc Prikazsky

Chairman and Chief Executive Officer
CEVA Santé Animale S.A

Author:

Tom Zerzan

President, Companion Animal
Phibro

Tom Zerzan

President, Companion Animal
Phibro

Author:

Alan Mackay

Executive Partner and Founder
GHO Capital

Alan Mackay

Executive Partner and Founder
GHO Capital

Author:

Linda Rhodes

VMD, PhD, Independent and ex-CSO
Independent Animal Health

Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.

Linda Rhodes

VMD, PhD, Independent and ex-CSO
Independent Animal Health

Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.

Author:

Kathy V. Turner

Corporate Vice President and Global Chief Marketing Officer
IDEXX

Ms. Turner has been Corporate Vice President of IDEXX since May 2014 and leads the Company’s Europe, Middle East and Asia (EMEA) Companion Animal Commercial Operations. Prior to joining the Company, from 1987 to May 2014, Ms. Turner held various leadership positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products and diagnostics. Most recently, Ms. Turner was Divisional Vice President of European Commercial Operations for the Diagnostics Division from 2011 to 2014, and prior to that, Divisional Vice President of Global Strategic Operations for the Diagnostics Division from 2007 to 2011. Ms. Turner holds a bachelor’s degree in marketing and advertising from Syracuse University.

Kathy V. Turner

Corporate Vice President and Global Chief Marketing Officer
IDEXX

Ms. Turner has been Corporate Vice President of IDEXX since May 2014 and leads the Company’s Europe, Middle East and Asia (EMEA) Companion Animal Commercial Operations. Prior to joining the Company, from 1987 to May 2014, Ms. Turner held various leadership positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products and diagnostics. Most recently, Ms. Turner was Divisional Vice President of European Commercial Operations for the Diagnostics Division from 2011 to 2014, and prior to that, Divisional Vice President of Global Strategic Operations for the Diagnostics Division from 2007 to 2011. Ms. Turner holds a bachelor’s degree in marketing and advertising from Syracuse University.

Author:

Dave Ross

Chief Executive Officer
Agri-EPI Centre Ltd

Dave Ross

Chief Executive Officer
Agri-EPI Centre Ltd

2021 Speakers

 

Amanda Boag

Group Referral Director
IVC Evidensia

Amanda Boag

Group Referral Director
IVC Evidensia

Amanda Boag

Group Referral Director
IVC Evidensia
 

Peter Dunkley

Director, CA Business Unit & UK Corporate Accounts
Zoetis UK


 

Peter Dunkley

Director, CA Business Unit & UK Corporate Accounts
Zoetis UK

Peter Dunkley

Director, CA Business Unit & UK Corporate Accounts
Zoetis UK


 

 

Caroline Collins

Managing Director
Pennard Vets

Caroline is a practicing Vet with over 15years experience and is Clinical Director at Pennard Vets. She believes in finding new and better ways to care for clients and their pets. It is this drive that has lead to constantly innovating and exploring Industry-leading advances to deliver this

Caroline Collins

Managing Director
Pennard Vets

Caroline Collins

Managing Director
Pennard Vets

Caroline is a practicing Vet with over 15years experience and is Clinical Director at Pennard Vets. She believes in finding new and better ways to care for clients and their pets. It is this drive that has lead to constantly innovating and exploring Industry-leading advances to deliver this

 

Nuala Summerfield

Co-Founder and Director
Virtual Veterinary Specialists

Nuala Summerfield

Co-Founder and Director
Virtual Veterinary Specialists

Nuala Summerfield

Co-Founder and Director
Virtual Veterinary Specialists
 

Dr Simon Doherty

Senior Lecturer (Education) in Animal Health & Welfare
Queens University Belfast (Institute of Global Food Security)

Dr Simon Doherty

Senior Lecturer (Education) in Animal Health & Welfare
Queens University Belfast (Institute of Global Food Security)

Dr Simon Doherty

Senior Lecturer (Education) in Animal Health & Welfare
Queens University Belfast (Institute of Global Food Security)
 

Chris Tufnell

Owner
Coach House Vets Ltd

Chris Tufnell

Owner
Coach House Vets Ltd

Chris Tufnell

Owner
Coach House Vets Ltd
 

Matthew Salois

Chief Economist and Head of Economics Division
AVMA

Matthew Salois

Chief Economist and Head of Economics Division
AVMA

Matthew Salois

Chief Economist and Head of Economics Division
AVMA
 

Charlie Barton

Co-Founder
Virtual Recall

Charlie Barton

Co-Founder
Virtual Recall

Charlie Barton

Co-Founder
Virtual Recall
 

Clint Latham, J.D

Director of Veterinary Data Security
Lucca Veterinary Data Security

Clint Latham, J.D

Director of Veterinary Data Security
Lucca Veterinary Data Security

Clint Latham, J.D

Director of Veterinary Data Security
Lucca Veterinary Data Security
 

Matt Dobbs

Global Chief Medical Officer
Destination Pet LLC

Matt Dobbs

Global Chief Medical Officer
Destination Pet LLC

Matt Dobbs

Global Chief Medical Officer
Destination Pet LLC
 

Mark Boddy

CEO
PawSquad

Mark Boddy

CEO
PawSquad

Mark Boddy

CEO
PawSquad
 

Dr. Thom Jenkins

Co-Founder & CEO
PetsApp

Thom is the Co-Founder and CEO of PetsApp - a client engagement platform for veterinary clinics. He is a vet by training, and has managed veterinary groups both in Asia and the UK.

Dr. Thom Jenkins

Co-Founder & CEO
PetsApp

Dr. Thom Jenkins

Co-Founder & CEO
PetsApp

Thom is the Co-Founder and CEO of PetsApp - a client engagement platform for veterinary clinics. He is a vet by training, and has managed veterinary groups both in Asia and the UK.

 

Adele Williams

Head of Equine and Data, Research and AI Exec Manager
Vet-AI

Adele Williams

Head of Equine and Data, Research and AI Exec Manager
Vet-AI

Adele Williams

Head of Equine and Data, Research and AI Exec Manager
Vet-AI
 

Susan Paterson

Director
Virtual VetDerms

Susan Paterson

Director
Virtual VetDerms

Susan Paterson

Director
Virtual VetDerms
 

Dr. Ivan Zakharenkov

Founder
Veterinary Integration Solutions

Dr. Ivan Zakharenkov

Founder
Veterinary Integration Solutions

Dr. Ivan Zakharenkov

Founder
Veterinary Integration Solutions
 

Apryle Horbal

President
VetNOW Virtual Care

Apryle Horbal

President
VetNOW Virtual Care

Apryle Horbal

President
VetNOW Virtual Care
 

Sebastian Gabor

Founder
Digitail

Sebastian Gabor

Founder
Digitail

Sebastian Gabor

Founder
Digitail
 

Nick Lloyd

Director
Vet XML Consortium

Nick Lloyd

Director
Vet XML Consortium

Nick Lloyd

Director
Vet XML Consortium
 

Bob Lester

Chief Medical Officer
WellHaven Pet Health

Bob Lester

Chief Medical Officer
WellHaven Pet Health

Bob Lester

Chief Medical Officer
WellHaven Pet Health
 

Audrey Wystrach DVM

Founder and Chief Executive Officer
Petfolk

Audrey Wystrach DVM

Founder and Chief Executive Officer
Petfolk

Audrey Wystrach DVM

Founder and Chief Executive Officer
Petfolk
 

Steven Eidelman

Founder & CEO
Modern Animal

Steven Eidelman

Founder & CEO
Modern Animal

Steven Eidelman

Founder & CEO
Modern Animal
 

Victoria Johnson

Founder & CEO
VetCT

Victoria Johnson

Founder & CEO
VetCT

Victoria Johnson

Founder & CEO
VetCT
 

Peter Renwick

Director
Plexi

Peter Renwick

Director
Plexi

Peter Renwick

Director
Plexi
 

Oliver Viner

Chief Operating Officer
VetHelpDirect

Oliver Viner

Chief Operating Officer
VetHelpDirect

Oliver Viner

Chief Operating Officer
VetHelpDirect

The Agenda

We are delighted to announce the 2021 agenda for the 3rd Annual Digital Veterinary Summit. Simply fill in your details on the right and download the PDF agenda immediately. 

Download the 2021 Agenda

2021 Partners

Associate Partner

Gold Digital Innovation Partner

Silver Event Partner

Visionary & Innovation Partner

Association Partner

Media Partners

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.

CONTACT US TO FIND OUT MORE

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Ticket price will increase in

Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us